Disease Management

The Centers for Disease Control and Prevention has updated its resources for health care providers on vaping-associated lung injury to include a poster for clinical settings.
The Food and Drug Administration yesterday approved a new pre-exposure prophylaxis (PrEP) for certain adults and adolescents who do not have HIV but are at risk for infection from sex.
The hepatitis C infection rate among women giving birth rose 400% between 2000 and 2015 to 4.1 per 1,000 deliveries, according to a study of hospital discharge data released today by the Centers for Disease Control and Prevention.
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which are in the same family of viruses as the Ebola virus outbreak in the Democratic Republic of the Congo.
The Centers for Disease Control and Prevention today updated the number of people with confirmed or probable lung injuries associated with electronic cigarette use or vaping products to 805 in 46 states and the U.S. Virgin Islands, including 12 deaths.
The Centers for Disease Control and Prevention today updated the number of people with confirmed or probable lung injuries associated with electronic cigarette use or vaping products to 530 in 38 states and the U.S. Virgin Islands, including seven deaths.
The Centers for Disease Control and Prevention today activated its Emergency Operations Center to enhance the inter-agency response to the outbreak of lung injuries associated with e-cigarette use.
Thirty-three states and the U.S. Virgin Islands have reported more than 450 possible cases of lung illness associated with using e-cigarette products, including five deaths, the Centers for Disease Control and Prevention announced Friday.
The Centers for Disease Control and Prevention last week issued a health advisory with information on the multistate outbreak of severe pulmonary disease associated with using e-cigarette products.
Medicare will cover nationally Chimeric Antigen Receptor T-cell therapies approved by the Food and Drug Administration to treat certain cancers, as well as off-label uses recommended by compendia approved by the Centers for Medicare & Medicaid Services.